Swatting away a takeover attempt, Zymeworks keeps retooling staff; After Cygnal-ing her exit from Flagship, Pearl Huang starts afresh

Paul Moore

Zymeworks used a poison pill maneuver a couple weeks ago as the counterpunch to a $773 million takeover bid by All Blue Falcons, and new CEO Kenneth Galbraith isn’t done piecing the staff together either.

Paul Moore will end his...

Click to view original post